This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, Y.-W. Articles by Lewis, B. C. Search for Related Content PubMed PubMed Citation Articles by Chen, Y.-W. Articles by Lewis, B. C.

Loss of p53 and Ink4a/Arf Cooperate in a Cell Autonomous Fashion to Induce Metastasis of Hepatocellular Carcinoma Cells

¹ Program in Gene Function and Expression, ² Program in Molecular Medicine, and ³ Memorial Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts; and ⁴ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York

Requests for reprints: Brian Lewis, University of Massachusetts Medical School, 364 Plantation Street, LRB 521, Worcester, MA 01605. Phone: 508-856-4325; Fax: 508-856-4650; E-mail: Brian.Lewis{at}umassmed.edu.

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. HCC patients frequently present with disease that has metastasized to other regions of the liver, the portal vein, lymph nodes, or lungs, leading to poor prognoses. Therefore, model systems that allow exploration of the molecular mechanisms underlying metastasis in this disease are greatly needed. We describe here a metastatic HCC model generated after the somatic introduction of the mouse polyoma virus middle T antigen to mice with liver-specific deletion of the Trp53 tumor suppressor locus and show the cell autonomous effect of p53 loss of function on HCC metastasis. We additionally find that cholangiocarcinoma also develops in these mice, and some tumors display features of both HCC and cholangiocarcinoma, suggestive of origin from liver progenitor cells. Concomitant loss of the Ink4a/Arf tumor suppressor locus accelerates tumor formation and metastasis, suggesting potential roles for the p16 and p19 tumor suppressors in this process. Significantly, tumor cell lines isolated from tumors lacking both Trp53 and Ink4a/Arf display enhanced invasion activity in vitro relative to those lacking Trp53 alone. Thus, our data illustrate a new model system amenable for the analysis of HCC metastasis. [Cancer Res 2007;67(16):7589–96]

This article has been cited by other articles:

				E. Ko, Y. Kim, S.-J. Kim, J.-W. Joh, S. Song, C.-K. Park, J. Park, and D.-H. Kim Promoter Hypermethylation of the p16 Gene Is Associated with Poor Prognosis in Recurrent Early-Stage Hepatocellular Carcinoma Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2260 - 2267. [Abstract] [Full Text] [PDF]

				Y.-W. Chen, S. Paliwal, K. Draheim, S. R. Grossman, and B. C. Lewis p19Arf Inhibits the Invasion of Hepatocellular Carcinoma Cells by Binding to C-terminal Binding Protein Cancer Res., January 15, 2008; 68(2): 476 - 482. [Abstract] [Full Text] [PDF]